Total Revenue |
2.19T |
1.83T |
1.56T |
Cost of Revenue |
1.41T |
1.17T |
997.39B |
Gross Profit |
779.01B |
667.25B |
559.34B |
Operating Expenses |
605.57B |
494.74B |
365.8B |
Research and Development |
41.52B |
39.2B |
30.54B |
Selling, General & Administrative Expenses |
564.05B |
87.58B |
33.4B |
Selling & Marketing Expenses |
3.45B |
87.58B |
16.73B |
General & Administrative Expenses |
560.59B |
21.1B |
16.67B |
Other Expenses |
0 |
29.29B |
7.44B |
Operating Income |
234.17B |
202.37B |
175.16B |
Total Other Income/Expenses Net |
-29.27B |
-25.77B |
-28.85B |
Income Before Tax |
204.91B |
171.09B |
144.11B |
Income Tax |
49.47B |
44.84B |
42.17B |
Net Income |
130.59B |
104.71B |
86.69B |
Basic EPS |
93.96 |
86.33 |
71.5 |
EPS Diluted |
93.88 |
86.26 |
71.43 |
Basic Average Shares |
1.39B |
1.21B |
1.21B |
Diluted Average Shares |
1.39B |
1.21B |
1.21B |
EBITDA |
277.28B |
303B |
269.04B |